QUOIN PHARMACEUTICALS LT-ADR (QNRX) Stock News

USA - NASDAQ:QNRX - US74907L4095 - ADR

9.01 USD

+0.44 (+5.13%)

Last: 11/7/2025, 8:10:47 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

QNRX Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results

3 days ago - By: Benzinga - Mentions: STVN PODD AMRK SOLV ...

Earnings Scheduled For November 6, 2025

10 days ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025

19 days ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

a month ago - By: Benzinga - Mentions: PDEX NDRA SRRK IMAB ...

12 Health Care Stocks Moving In Monday's Intraday Session

a month ago - By: Stocktwits

QNRX Stock Soars 300% After $104.5M Financing Through Private Placement

a month ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million

2 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome

3 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome

3 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy

3 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton

3 months ago - By: The Motley Fool

Quoin (QNRX) Q2 Loss Beats Estimates

3 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update

3 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025

3 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Provides Product Portfolio Update

5 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin Diseases

6 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study

6 months ago - By: Quoin Pharmaceuticals, Inc.

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome

6 months ago - By: Stocktwits

Retail Buzz Intensifies Around Quoin Pharma Stock After Positive Pediatric Skin Study Data